OVERSTITCH 2-0 POLYPROPYLENE SUTURE
Report
- Report Number
- 3005099803-2025-06280
- Event Type
- Injury
- Date Received
- November 21, 2025
- Date of Event
- October 17, 2025
- Report Date
- January 13, 2026
- Manufacturer
- APOLLO ENDOSURGERY
- Product Code
- OCW
- PMA / PMN Number
- K181141
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
BLOCK D4, H4 DETAILED PRODUCT INFORMATION WAS NOT PROVIDED TO BSC. WE COMPLETED A GOOD FAITH EFFORT TO OBTAIN THE INFORMATION. BECAUSE THE PRODUCT IS UNKNOWN AT THIS TIME, WE ARE UNABLE TO PROVIDE THE COMPLETE UDI AND OTHER PRODUCT SPECIFIC INFORMATION. IF ADDITIONAL DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. BLOCK H6 DEVICE CODE A040609 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF ANCHOR BENT. IMDRF CODE F2301 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF ADDITIONAL DEVICE REQUIRED. IMDRF CODE F1901 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF ADDITIONAL SURGERY. IMDRF CODE E0506 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF HEMORRHAGE, MAJOR.
BLOCK D4, H4. DETAILED PRODUCT INFORMATION WAS NOT PROVIDED TO BSC. WE COMPLETED A GOOD FAITH EFFORT TO OBTAIN THE INFORMATION. BECAUSE THE PRODUCT IS UNKNOWN AT THIS TIME, WE ARE UNABLE TO PROVIDE THE COMPLETE UDI AND OTHER PRODUCT SPECIFIC INFORMATION. IF ADDITIONAL DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. BLOCK H6. DEVICE CODE A040609 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF ANCHOR BENT. IMDRF CODE F2301 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF ADDITIONAL DEVICE REQUIRED. IMDRF CODE F1901 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF ADDITIONAL SURGERY. IMDRF CODE E0506 IS BEING USED TO CAPTURE THE REPORTABLE EVENT OF HEMORRHAGE, MAJOR. DEVICE EVALUATION: BLOCK H11: THE DEVICE DID NOT RETURN FOR ANALYSIS HOWEVER THE CUSTOMER PROVIDED SOME PICTURES. A MEDIA INSPECTION WAS PERFORMED, WHERE IT IS POSSIBLE TO IDENTIFY THE ANCHOR OF THE OVERSTITCH SUTURE BENT INTO THE NEEDLE OF OVERSTITCH. ADDITIONALLY, A SHORT PIECE OF A BROKEN SUTURE CAN BE SEEN. BASED ON THE EVENT DESCRIPTION, MEDIA INSPECTION, AND INFORMATION PROVIDED BY THE CUSTOMER THERE IS NOT ENOUGH EVIDENCE TO DETERMINE WHETHER THE ANCHOR BENT AND SUTURE BREAK WAS DUE TO THE PHYSICIAN'S TECHNIQUE DURING THE PROCEDURE OR WAS RELATED TO A DEVICE MALFUNCTION. CAUSE NOT ESTABLISHED IS SELECTED AS THE MOST PROBABLE CAUSE FOR THIS EVENT. FOR THE EVENTS ADDITIONAL DEVICE REQUIRED, INADEQUATE/INAPPROPRIATE TREATMENT OR DIAGNOSTIC EXPOSURE, AND ADDITIONAL SURGERY, IT HAPPENED DURING THE PROCEDURE, AND THE MOST PROBABLE CAUSE OF THIS REPORTED ISSUE CANNOT BE ESTABLISHED DUE TO LACK OF EVIDENCE. FOR THIS REASON, WILL BE CLASSIFIED AS CAUSE NOT ESTABLISHED. IN ACCORDANCE WITH THE CUSTOMER'S EVENT DESCRIPTION AND INFORMATION PROVIDED, FOR THE EVENTS HEMORRHAGE, MAJOR AND TISSUE THESE ARE POTENTIAL ADVERSE EVENTS ASSOCIATED WITH THE USE OF THE DEVICE. FOR THIS REASON, THE EVENT IS CATALOGUED AS "KNOWN INHERENT RISK OF DEVICE" BECAUSE THE REPORTED ADVERSE EVENT KNOWN AND DOCUMENTED IN THE LABELING (INCLUDING BOTH SHORT OR LONG TERM KNOWN COMPLICATIONS OR ADVERSE REACTIONS). THERE IS NO EVIDENCE THE DEVICE WAS IMPROPERLY USED PER THE INSTRUCTIONS FOR USE (IFU), AND THERE IS NO EVIDENCE THAT THERE IS ANY ISSUE WITH TRANSLATION, WORDING, OR GRAPHICS OF THE IFU/LABELING INFORMATION.
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN OVERSTITCH ENDOSCOPIC SUTURE SYSTEM WAS USED DURING A FISTULA REPAIR ON (B)(6) 2025. DURING THE PROCEDURE, THE NEEDLE SHAFT WAS BENT. UPON REMOVAL OF THE FIRST OVERSTITCH DEVICE, IT WAS OBSERVED THERE WAS TISSUE DAMAGE TO THE ESOPHAGUS, WHICH CAUSED MAJOR BLEEDING. THE BLEEDING WAS TREATED WITH PURASTAT. AN ATTEMPT WAS MADE TO COMPLETE THE PROCEDURE WITH A SECOND OVERSTITCH DEVICE, WHICH WAS ALSO BENT. THE SECOND OVERSTITCH DEVICE DID NOT CAUSE ANY COMPLICATIONS. THE PHYSICIAN ATTEMPTED TO CLOSE THE FISTULA USING CLIPS. HOWEVER, THE CLIPS WERE NOT SUCCESSFUL. THE PATIENT HAD AN ADDITIONAL SURGERY TO SUCCESSFULLY CLOSE THE FISTULA. THE PATIENT HAS MADE A FULL RECOVERY. THIS REPORT IS RELATED TO THE FIRST OF TWO OVERSTITCH SUTURES AND TWO OVERSTITCH DEVICES USED IN THE SAME PROCEDURE. PLEASE REFER TO REPORTS 3005099803-2025-06116 FOR THE FIRST OVERSTITCH DEVICE, 3005099803-2025-06117 FOR THE SECOND OVERSTITCH DEVICE, AND 3005099803-2025-06281 FOR THE SECOND OVERSTITCH SUTURE.
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN OVERSTITCH ENDOSCOPIC SUTURE SYSTEM WAS USED DURING A FISTULA REPAIR ON OCTOBER 17, 2025. DURING THE PROCEDURE, THE NEEDLE SHAFT WAS BENT. UPON REMOVAL OF THE FIRST OVERSTITCH DEVICE, IT WAS OBSERVED THERE WAS TISSUE DAMAGE TO THE ESOPHAGUS, WHICH CAUSED MAJOR BLEEDING. THE BLEEDING WAS TREATED WITH PURASTAT. AN ATTEMPT WAS MADE TO COMPLETE THE PROCEDURE WITH A SECOND OVERSTITCH DEVICE, WHICH WAS ALSO BENT. THE SECOND OVERSTITCH DEVICE DID NOT CAUSE ANY COMPLICATIONS. THE PHYSICIAN ATTEMPTED TO CLOSE THE FISTULA USING CLIPS. HOWEVER, THE CLIPS WERE NOT SUCCESSFUL. THE PATIENT HAD AN ADDITIONAL SURGERY TO SUCCESSFULLY CLOSE THE FISTULA. THE PATIENT HAS MADE A FULL RECOVERY. THIS REPORT IS RELATED TO THE FIRST OF TWO OVERSTITCH SUTURES AND TWO OVERSTITCH DEVICES USED IN THE SAME PROCEDURE. PLEASE REFER TO REPORTS 3005099803-2025-06116 FOR THE FIRST OVERSTITCH DEVICE, 3005099803-2025-06117 FOR THE SECOND OVERSTITCH DEVICE, AND 3005099803-2025-06281 FOR THE SECOND OVERSTITCH SUTURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2024511 | OVERSTITCH 2-0 POLYPROPYLENE SUTURE | ENDOSCOPIC TISSUE APPROXIMATION DEVICE | OCW | APOLLO ENDOSURGERY | UNK-P-OVERSTITCH_SUTURE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Required Intervention |